Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Malar J. 2008 Dec 16;7:257. doi: 10.1186/1475-2875-7-257.

Does the drug sensitivity of malaria parasites depend on their virulence?

Author information

  • 1Institutes of Evolution, Immunology and Infection Research, University of Edinburgh, EH9 3JT, UK. petra.schneider@ed.ac.uk

Abstract

BACKGROUND:

Chemotherapy can prompt the evolution of classical drug resistance, but selection can also favour other parasite traits that confer a survival advantage in the presence of drugs. The experiments reported here test the hypothesis that sub-optimal drug treatment of malaria parasites might generate survival and transmission advantages for virulent parasites.

METHODS:

Two Plasmodium chabaudi lines, one derived from the other by serial passage, were used to establish avirulent and virulent infections in mice. After five days, infections were treated with various doses of pyrimethamine administered over 1 or 4 days. Virulence measures (weight and anaemia), parasite and gametocyte dynamics were followed until day 21.

RESULTS:

All treatment regimes reduced parasite and gametocyte densities, but infections with the virulent line always produced more parasites and more gametocytes than infections with the avirulent line. Consistent with our hypothesis, drug treatment was disproportionately effective against the less virulent parasites. Treatment did not affect the relative transmission advantage of the virulent line. Neither of the lines contained known mutations conferring classical drug resistance.

CONCLUSION:

Drug-sensitivity of malaria parasites can be virulence-dependent, with virulent parasites more likely to survive sub-optimal treatment. If this proves to be general for a variety of drugs and parasite species, selection imposed by sub-optimal drug treatment could result in the evolution of more aggressive malaria parasites.

PMID:
19087299
[PubMed - indexed for MEDLINE]
PMCID:
PMC2636820
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk